Ovid Therapeutics: Alexander Previously Served as Chief Strategy Officer and Chief Corporate Affairs Officer >OVID

Dow JonesSep 11 08:01 ET

Press Release: Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth

Dow JonesSep 11 08:00 ET

Ovid Therapeutics to Present at Upcoming September Investor Conferences

GlobeNewswireSep 4 08:00 ET

Ovid Therapeutics (OVID) Upgraded to Buy: Here's Why

Zacks Aug 20 11:10 ET

Ovid Therapeutics Analyst Ratings

BenzingaAug 19 07:23 ET · Ratings

H.C. Wainwright Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsAug 19 06:31 ET · Ratings